Article Versions Notes

De Jesús-González LA, del Ángel RM, Palacios-Rápalo SN, Cordero-Rivera CD, Rodríguez-Carlos A, Trujillo-Paez JV, Farfan-Morales CN, Osuna-Ramos JF, Reyes-Ruiz JM, Rivas-Santiago B, et al. A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin. Microorganisms. 2024; 12(2):383. https://doi.org/10.3390/microorganisms12020383

De Jesús-González, Luis Adrián, Rosa María del Ángel, Selvin Noé Palacios-Rápalo, Carlos Daniel Cordero-Rivera, Adrián Rodríguez-Carlos, Juan Valentin Trujillo-Paez, Carlos Noe Farfan-Morales, Juan Fidel Osuna-Ramos, José Manuel Reyes-Ruiz, Bruno Rivas-Santiago, and et al. 2024. "A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin" Microorganisms 12, no. 2: 383. https://doi.org/10.3390/microorganisms12020383

De Jesús-González, L. A., del Ángel, R. M., Palacios-Rápalo, S. N., Cordero-Rivera, C. D., Rodríguez-Carlos, A., Trujillo-Paez, J. V., Farfan-Morales, C. N., Osuna-Ramos, J. F., Reyes-Ruiz, J. M., Rivas-Santiago, B., León-Juárez, M., García-Herrera, A. C., Ramos-Cortes, A. C., López-Gándara, E. A., & Martínez-Rodríguez, E. (2024). A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin. Microorganisms, 12(2), 383. https://doi.org/10.3390/microorganisms12020383